Law firm probes Stryker over unresolved manufacturing issues causing stock drop

Pomerantz LLP is investigating Stryker Corp. for potential securities fraud after the company revealed ongoing manufacturing problems in its peripheral vascular business. The issue, initially expected to be resolved in Q3 2026, has persisted into Q4, leading to an 8.81% drop in Stryker's stock price. This investigation could impact investor confidence and lead to legal action if wrongdoing is found.

Stryker Corporation (SYK) trades at USD 283.72 on Pluang as of Oct 14, 2026 05:21 WIB, showing a modest 0.40% gain in the last day despite the reported manufacturing issues. The stock's market cap stands at $108.40 billion, with a high volume of 1,810,418 shares traded, and a strong sell sentiment of 98% in Pluang orders. This trading activity provides current market context to the ongoing investigation highlighted in the news.